By Drug Target Review –
Scientists have discovered a new sugar molecule from deep-sea bacteria that could lead to new cancer therapies. The molecule, called EPS3.9, is an exopolysaccharide – a long-chain sugar – produced by the bacterium Spongiibacter nanhainus CSC3.9. According to the study, published in The FASEB Journal, EPS3.9 promotes pyroptosis – an inflammatory form of programmed cell death – effectively killing tumour cells and suppressing tumour growth.
What is pyroptosis and why does it matter?
Pyroptosis is a type of cell death distinct from apoptosis- characterised by inflammation and the release of signalling molecules that activate the immune system. This inflammatory response can be beneficial in cancer therapy, as it not only eliminates cancer cells but also recruits the body’s defences to attack tumours.
